FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2317861010> ?p ?o ?g. }

• W2317861010 endingPage "517" @default.
• W2317861010 startingPage "511" @default.
• W2317861010 abstract "1. Orbital accumulation of hydrophilic, interstitial glycosaminoglycans (GAGs) and subsequent expansion of retrobulbar tissue lead to the clinical manifestation of exophthalmos in patients with Graves' eye disease. 2. A highly specific method to determine the concentration and biochemical composition of different GAGs was developed in order to obtain a sensitive test system for the activity of the disease. By means of this method, GAG excretion in 24 h urine collections of 56 patients and 21 controls was analysed by precipitation with cetylpyridinium chloride and potassium acetate in ethanol, followed by sequential enzymic hydrolysis with chondroitin AC lyase, chondroitin ABC lyase and hyaluronate lyase, with HPLC analysis of the resulting α,β-unsaturated disaccharides by anion-exchange chromatography. 3. Concentrations of GAG, chondroitin sulphate A (CA), dermatan sulphate (DS) and hyaluronic acid (HA) were determined in patients and controls, with high recovery rates [72.2 ± 5.3%, mean ± SEM; detection limit, 4.2 μg/l (0.01 μmol/l)], revealing marked differences in urinary concentrations of total GAG and HA, as well as an elevation of CA in patients compared with controls. 4. Method sensitivity was 0.86 for patients with active Graves' eye disease, and 0.87 for patients with untreated ophthalmopathy, whereas specificity was 1.0 for patients with inactive disease. Patients with increased GAG concentration responded well to steroids and/or orbital irradiation (before therapy: GAG, 111.49 ± 40.32; CA, 59.58 ± 21.34; DS, 25.05 ± 8.12; HA, 26.88 ± 11.63 mg/24 h; during therapy: GAG, 54.22 ± 10.94; CA, 20.52 ± 4.58; DS, 17.65 ± 3.46; HA, 16.05 ± 3.69 mg/24 h), whereas GAG excretion increased markedly 2–3 months after stopping prednisone therapy in patients with still active eye disease (GAG, 109.9 ± 10.51; CA, 63.8 ± 7.34; DS, 24.1 ± 5.07; HA, 22.0 ± 6.28 mg/24 h). 5. This sensitive method determines the nature of renally excreted GAGs, reflecting the aberrant synthesis pattern of fibroblasts in patients with Graves' disease." @default.
• W2317861010 created "2016-06-24" @default.
• W2317861010 creator A5004229691 @default.
• W2317861010 creator A5053666302 @default.
• W2317861010 creator A5064586974 @default.
• W2317861010 creator A5077670238 @default.
• W2317861010 creator A5087797414 @default.
• W2317861010 creator A5090185043 @default.
• W2317861010 date "1997-05-01" @default.
• W2317861010 modified "2023-10-17" @default.
• W2317861010 title "HPLC Glycosaminoglycan Analysis in Patients with Graves' Disease" @default.
• W2317861010 cites W1217411098 @default.
• W2317861010 cites W1966754802 @default.
• W2317861010 cites W1971366877 @default.
• W2317861010 cites W1973225811 @default.
• W2317861010 cites W1974581572 @default.
• W2317861010 cites W1999652145 @default.
• W2317861010 cites W2004722439 @default.
• W2317861010 cites W2065001328 @default.
• W2317861010 cites W2072029917 @default.
• W2317861010 cites W2081151294 @default.
• W2317861010 cites W2114649506 @default.
• W2317861010 cites W2164637065 @default.
• W2317861010 cites W2166227856 @default.
• W2317861010 cites W2169215794 @default.
• W2317861010 cites W2473559300 @default.
• W2317861010 cites W648500737 @default.
• W2317861010 doi "https://doi.org/10.1042/cs0920511" @default.
• W2317861010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9176026" @default.
• W2317861010 hasPublicationYear "1997" @default.
• W2317861010 type Work @default.
• W2317861010 sameAs 2317861010 @default.
• W2317861010 citedByCount "35" @default.
• W2317861010 countsByYear W23178610102012 @default.
• W2317861010 countsByYear W23178610102014 @default.
• W2317861010 countsByYear W23178610102015 @default.
• W2317861010 countsByYear W23178610102018 @default.
• W2317861010 countsByYear W23178610102020 @default.
• W2317861010 countsByYear W23178610102021 @default.
• W2317861010 countsByYear W23178610102022 @default.
• W2317861010 crossrefType "journal-article" @default.
• W2317861010 hasAuthorship W2317861010A5004229691 @default.
• W2317861010 hasAuthorship W2317861010A5053666302 @default.
• W2317861010 hasAuthorship W2317861010A5064586974 @default.
• W2317861010 hasAuthorship W2317861010A5077670238 @default.
• W2317861010 hasAuthorship W2317861010A5087797414 @default.
• W2317861010 hasAuthorship W2317861010A5090185043 @default.
• W2317861010 hasConcept C10146269 @default.
• W2317861010 hasConcept C105702510 @default.
• W2317861010 hasConcept C126322002 @default.
• W2317861010 hasConcept C134018914 @default.
• W2317861010 hasConcept C153074725 @default.
• W2317861010 hasConcept C179998833 @default.
• W2317861010 hasConcept C185592680 @default.
• W2317861010 hasConcept C2776652619 @default.
• W2317861010 hasConcept C2776685619 @default.
• W2317861010 hasConcept C2776735749 @default.
• W2317861010 hasConcept C2777529286 @default.
• W2317861010 hasConcept C2778066728 @default.
• W2317861010 hasConcept C2779134260 @default.
• W2317861010 hasConcept C2779553658 @default.
• W2317861010 hasConcept C2780026642 @default.
• W2317861010 hasConcept C43617362 @default.
• W2317861010 hasConcept C55493867 @default.
• W2317861010 hasConcept C71924100 @default.
• W2317861010 hasConceptScore W2317861010C10146269 @default.
• W2317861010 hasConceptScore W2317861010C105702510 @default.
• W2317861010 hasConceptScore W2317861010C126322002 @default.
• W2317861010 hasConceptScore W2317861010C134018914 @default.
• W2317861010 hasConceptScore W2317861010C153074725 @default.
• W2317861010 hasConceptScore W2317861010C179998833 @default.
• W2317861010 hasConceptScore W2317861010C185592680 @default.
• W2317861010 hasConceptScore W2317861010C2776652619 @default.
• W2317861010 hasConceptScore W2317861010C2776685619 @default.
• W2317861010 hasConceptScore W2317861010C2776735749 @default.
• W2317861010 hasConceptScore W2317861010C2777529286 @default.
• W2317861010 hasConceptScore W2317861010C2778066728 @default.
• W2317861010 hasConceptScore W2317861010C2779134260 @default.
• W2317861010 hasConceptScore W2317861010C2779553658 @default.
• W2317861010 hasConceptScore W2317861010C2780026642 @default.
• W2317861010 hasConceptScore W2317861010C43617362 @default.
• W2317861010 hasConceptScore W2317861010C55493867 @default.
• W2317861010 hasConceptScore W2317861010C71924100 @default.
• W2317861010 hasIssue "5" @default.
• W2317861010 hasLocation W23178610101 @default.
• W2317861010 hasLocation W23178610102 @default.
• W2317861010 hasOpenAccess W2317861010 @default.
• W2317861010 hasPrimaryLocation W23178610101 @default.
• W2317861010 hasRelatedWork W1973692647 @default.
• W2317861010 hasRelatedWork W1981174944 @default.
• W2317861010 hasRelatedWork W1987542667 @default.
• W2317861010 hasRelatedWork W2020201209 @default.
• W2317861010 hasRelatedWork W2072795689 @default.
• W2317861010 hasRelatedWork W2074650400 @default.
• W2317861010 hasRelatedWork W2093871648 @default.
• W2317861010 hasRelatedWork W2467750379 @default.
• W2317861010 hasRelatedWork W2470608420 @default.
• W2317861010 hasRelatedWork W1772939976 @default.

• next